Karyopharm Therapeutics Inc (NAS:KPTI)
$ 1.09 0.02 (1.87%) Market Cap: 126.95 Mil Enterprise Value: 112.52 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 76/100

Karyopharm Therapeutics Inc at Barclays Global Healthcare Conference (Virtual) Transcript

Mar 09, 2021 / 02:10PM GMT
Release Date Price: $11.48 (+3.52%)
Peter Richard Lawson
Barclays Bank PLC, Research Division - Research Analyst

Great. Thank you. Good morning, everyone. Welcome to Barclays Global Healthcare Conference. My name is Peter Lawson. I'm one of the biotech equity analysts at Barclays. I just want to thank everyone for taking the time out of the day. I've got a series of questions, but do ping me by e-mail, so it's [email protected] or ping me on Bloomberg.

It gives me a great pleasure to introduce the management team from Karyopharm today. I've got Michael Kauffman and various other members of management team as well on the line.

Questions & Answers

Peter Richard Lawson
Barclays Bank PLC, Research Division - Research Analyst

And so maybe it's just an opening question as kind of a 2- to 3-minute kind of overview kind of the company's differentiation in the oncology space, what would you kind of define as Karyopharm's core competencies?

Michael G. Kauffman
Karyopharm Therapeutics Inc. - Co-Founder, CEO & Director

Yes. Well

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot